Speakers

Johannes Keuschnigg leads a Regulatory Device team at Sandoz. He has of >10 years of experience in developing and registering drug-device combination products. His current remit includes substitutable, complex generics and (interchangeable) biosimilars from early development through initial submissions into life cycle management. Johannes holds a M.Sc. in Molecular Biology from the Leopold-Franzens University Innsbruck, Austria and a Ph.D. in Medical Microbiology and Immunology from the University of Turku, Finland.